Similar articles

• [Immunological problems in organ transplantation (with reference to oncology)].

  Gazzera G. Gazzera G. G Batteriol Virol Immunol Ann Osp Maria Vittor Torino. 1970 Sep-Oct;63(9):599-614. G Batteriol Virol Immunol Ann Osp Maria Vittor Torino. 1970. PMID: 4932115 Italian. No abstract available.
• The ocular immune response. II. Immune rejection of penetrating corneal homografts. Early versus late treatment with antilymphocyte serum.

  Waltman SR, Burde RM, Faulkner HW. Waltman SR, et al. Transplantation. 1969 Aug;8(2):147-51. Transplantation. 1969. PMID: 4896328 No abstract available.
• Modification of the ocular immune response. I. Use of antilymphocytic serum to prevent immune rejection of penetrating corneal homografts.

  Waltman SR, Faulkner HW, Burde RM. Waltman SR, et al. Invest Ophthalmol. 1969 Apr;8(2):196-200. Invest Ophthalmol. 1969. PMID: 4887870 No abstract available.
• [Immunological concepts relating to organ transplantation].

  Dei Poli G, Massa G, Rosso PA, Dei Poli N. Dei Poli G, et al. Minerva Chir. 1980 Jun 15;35(11):829-78. Minerva Chir. 1980. PMID: 6450338 Review. Italian. No abstract available.
• Modification of renal allograft rejection in man.

  Carpenter CB, Merrill JP. Carpenter CB, et al. Arch Intern Med. 1969 May;123(5):501-13. Arch Intern Med. 1969. PMID: 4888969 Review. No abstract available.